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Successful Liver Transplantation despite 
Evidence of Acute Toxoplasmosis 
I. U~kay*, C. van De[den. Division des Maladies 
InJ:ectieuses HOpitaux Universitaires de G~neve, 
Switzerland 
Background: Symptomatic reactivation or sero- 
logic evidence for primary infection by Toxoplasma 
gondii in a potential recipient is usually considered 
as a relative contraindication for elective liver 
transplantation. 
Methods: We present a case of a successful liver 
transplantation in a female patient with concomi- 
tant serologic evidence of acute toxop[asmosis. 
Report: A 25 year old woman was hospitalized 
for life-threatening hepatic failure due to Hepati- 
tis B Virus infection. Liver transplantation had to 
be performed in extreme emergency because of 
rapidly worsening hepatic encepha[opathy. The re- 
cipient's pre-transp[ant serology screening revealed 
the presence of high titers of IgM and IgA an- 
tibodies for T. gondii, whereas IgG were unde- 
tectab[e. This positive serology was confirmed by 
a capture technique as we[[ as by immunofluo- 
rescence. Thus the diagnosis of concomitant pri- 
mary infection by T. gondii was made. Immunosup- 
pression consisted of tacro[imus, mycopheno[ate 
mofeti[ and prednisone. Preemptive therapy with 
intravenous c[indamycin and trimethoprime/suffa/ 
methoxazo[e was initiated, and switched to per 
oral pyrimethamine and su[fadiazine after 7 days 
for a total of six weeks. No adverse events or 
symptomatic disease occurred, and the patient was 
finally discharged with a secondary prophylaxis of 
trimethoprime/suffamethoxazo[e scheduled for at 
[east one year. So far she remains asymptomatic six 
months after transplantation. 
Conclusion: This case report suggests that sero- 
logic evidence for acute toxop[asmosis should not 
be considered as a contraindication for liver trans- 
plantation under the condition that concomitant 
antimicrobio[ogica[ treatment is provided. 
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Background: Bacteremia is a significant compli- 
cation and one of the major infections in liver 
transplantation (LT). This study is an analysis of 
bacteria[ infections of blood in early post trans- 
plant period. 
Materials/Methods: The study comprised the 
83 adults patients undergoing liver transplantation 
(piggy back technique), between September 2001 
and October 2004. A[[ the patients were followed 
prospectively for blood infections from the clay 
of LT and in the first four weeks after operation. 
The samples of clinical materials, blood and ves- 
sels, catheters, were investigated for bacteriolog- 
ical cultures. The microorganisms were cultured 
and identified according to standard Bacteriologi- 
cal procedures. The susceptibility testing was clone 
by the National Committee for Clinical Laboratory 
Standards (NCCLS) procedures. 
Results: The blood specimens were examined in 
59 recipients (71.1%) before operation and in 76 pa- 
tients (91.6%) during first month after transplan- 
tation. In total 249 samples were investigated, 
96 of them were positive. The bacteria[ strains 
were cultured from 19 recipients before LT and 
from 48 patients after operation. Out of the 
bacteria[ strains, the most common were Gram- 
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positive cocci - 71 isolates. The coagu[ase-negative 
staphylococci - 52 isolates (the Methici[[in Re- 
sistant Coagu[ase-Negative Staphylococci MRCNS 
strains were detected). The Enterococcus spp. oc- 
curred in 9 isolates (the High Level Aminog[yco- 
side Resistant HLAR enterococci strains were cub 
tured). The Enterobacteriaceae family - 16 isolates 
and 15 isolates of Gram-negative nonfermenting 
rods were detected, some of Gram-negative rods 
were Extended-Spectrum Beta-Lactamases ESBL (+) 
strains. 
Conclusions: 1. The domination of Gram-positive 
cocci in bacteriemia is caused by coagu[ase- 
negative staphylococci (a frequent cause of noso- 
comia[ catheter-related bloodstream infections) 
and may be due to the use of antimicrobia[ 
prophylaxis which reduces Gram-negative bacte- 
ria[ strains. 2. The increased rate of isolation of 
Multi-Drug-Resistant (MDR) bacteria to antimicro- 
bia[ agents may be due to the frequent use of 
these agents for prophylaxis of bacteria[ infections 
in liver transplant recipients. These MDR bacteria[ 
strains caused severe blood infections in patients 
after LT. 
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Fungal Infections of Blood in Patients 
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Susceptibility of the Fungal Strains 
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Medicine and Internal Diseases, Transplantation 
Institute, Medical University o[ Warsaw, Poland, 
4Department o[ Transplant Medicine and 
Nephrology, Transplantation Institute, Medical 
University o[ Warsaw, Poland 
Background: Funga[ infections caused by multi- 
drug resistant strains are increasing clinical prob- 
lems in immunocompromised patients. 
Objectives: Estimation of frequency of funga[ iso- 
lates from specimens obtained from immunocom- 
promised patients hospitalized from February 2005 
to February 2006, in the Transplantation Institute 
of the Medical University of Warsaw, and assess- 
ment of their susceptibility to antifunga[ agents. 
Methods: Specimens sent for culture comprised of 
blood samples and vessels catheters. The isolation 
and identification of cultured fungi was done ac- 
cording to standard mycological procedures and 
commercially available test ID 32C and API Candida 
Tests (bioMerieux). Susceptibility of the strains to 
antifunga[ agents was made by E-test (AB Biodisk). 
Results: Funga[ cultures were positive in 27 pa- 
tients. In total 61 strains of yeast-like fungi were 
isolated. Fifty strains were isolated from blood 
and 11 strains from catheters. The most commonly 
isolated species were: C. parapsilosis - 44, C. al- 
bicans - 9, C. tropicalis - 3, C. guilliermondii -
3, C. glabrata - 1 C. krusei - 1. A[[ strains were 
susceptible to amphotericin B and caspofungin, 
Voriconazo[e - 98.4%, Itraconazo[e - 85.25%, F[u- 
conazo[e - 82%. Non-a[bicans Candida strains were 
characterized by lower susceptibility to many com- 
monly used antifunga[ agents. 
Conclusions: The most common funga[ pathogen 
isolated from clinical specimens was C. parapsilo- 
sis -72.1%. A[[ funga[ strains were susceptible to 
amphotericin B and caspofungin. The emergence 
of multi-drug resistant non-a[bicans Candida spp. 
warrants modification of antifunga[ therapy and 
prophylaxis, particularly in immunocompromisecl 
patients. 
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Invasive Fungal Infections in Liver Recipients 
O. Kurt Azap*, E. Kursun, E Timurkaynak, 
H. Ars[an, B. Demvhan, M. HaberaL Baskent 
University Faculty o[ Medicine, Ankara, Turkey 
Background: Invasive funga[ infections are com- 
mon following orthotopic liver transplantation and 
are reported to occur in 6-47% of liver transplant 
recipients. Recent experience suggests that the 
overall incidence of this complication has declined 
clue to improved surgical techniques, the avail- 
ability of newer, more specific immunosuppressive 
agents with less dependence on g[ucocorticoids and 
the use of antifunga[ prophylaxis in certain circum- 
stances. The dominant funga[ pathogens in liver 
transplant recipients are Candida spp., accounting 
for over 80% of IFIs in this group. The aim of this 
study is to evaluate the funga[ infections and the 
etiologic agents in the liver recipients. 
Materials and Methods: A total of 91 liver trans- 
plantations were performed between the period 
2001 and 2005 at Baskent University Faculty of 
Medicine. Medical records of these patients were 
evaluated retrospectively. 
